GlassScriptPhysician profile
Brian K Rich
NPI 1063436947
$245,151.08
in general payments reported to CMS, 2019-2025
25 companies · $43.45 in 2025
The $43.45 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $18K · 2021: $78K · 2022: $119K · 2023: $14K · 2024: $547 · 2025: $43.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $1,187 · Travel and Lodging: $289 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,500.00 |
| Food and Beverage | $1,187.27 |
| Travel and Lodging | $289.38 |
| Education | $132.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Spine, LLC | $160,772.74 | 2020-2022 | |
| Stimwave Technologies Incorporated | $44,975.76 | 2019-2022 | |
| Curonix LLC | $12,907.65 | 2022-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $9,037.36 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Genesys Orthopedics Systems, L.L.C. | $6,680.88 | 2020-2021 | |
| Interventional Pain Technologies INC. | $4,661.11 | 2021-2023 | Vyrsa Fix |
| Medtronic USA, INC. | $1,514.32 | 2019 | |
| Omnia Medical, LLC | $1,200.00 | 2020 | |
| Spinefrontier, INC. | $954.27 | 2019 | |
| Camber Spine Technologies LLC | $796.17 | 2021-2022 | |
| Abbott Laboratories | $390.57 | 2020-2025 | Eterna, Proclaim |
| Stratus Medical, LLC | $324.32 | 2022 | |
| Vertiflex, INC. | $240.89 | 2019 | |
| Life Spine, INC. | $199.76 | 2019-2022 | |
| Si-Bone, INC. | $133.65 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $129.62 | 2020-2024 | Senza |
| Vertos Medical, INC. | $55.04 | 2022 | |
| Stryker Corporation | $40.18 | 2020 | |
| Spinal Simplicity, LLC | $37.07 | 2020 | |
| Tandem Diabetes Care, INC. | $19.77 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi Pasteur INC. | $18.89 | 2023 | |
| Forte Bio-Pharma LLC | $17.65 | 2024 | Prolate, Nalocet |
| Medtronic Vascular, INC. | $16.78 | 2020 | |
| Scilex Pharmaceuticals INC. | $13.44 | 2022 | |
| Novo Nordisk INC | $13.19 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.